Skip to main content
. Author manuscript; available in PMC: 2012 Mar 1.
Published in final edited form as: Cancer Res. 2011 Mar 1;71(5):1573–1583. doi: 10.1158/0008-5472.CAN-10-3126

Figure 6. Effects of mTOR inhibition after cessation of VEGFR inhibition.

Figure 6

A. Confocal images of tumor blood vessels (CD31; green) and quantification of CD31 area density are shown. B. Confocal images and quantification of the erythrocyte marker, TER-119 (red). Scale bar in B represents 100μm in A and B. *P<0.05 vs. vehicle. †P<0.05 vs. OSI-930. ‡P<0.05 vs. OSI-930 7d, Vehicle 4d. §P<0.05 vs. OSI-930 7d, OXA-01 4d.